Ensysce Biosciences Inc (NAS:ENSC)
$ 0.522 -0.0565 (-9.77%) Market Cap: 7.79 Mil Enterprise Value: 7.88 Mil PE Ratio: 0 PB Ratio: 2.37 GF Score: 35/100

Ensysce Biosciences Inc Extraordinary Shareholders Meeting Transcript

Jan 26, 2022 / 05:00 PM GMT
Release Date Price: $436.8 (-11.22%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ENSC.OQ - Ensysce Biosciences Inc
Ensysce Biosciences Inc Extraordinary Shareholders Meeting
Jan 26, 2022 / 05:00PM GMT

=====================
Corporate Participants
=====================
* Bob Gower
Ensysce Biosciences, Inc. - Chairman of the Board
* David Humphrey
Ensysce Biosciences, Inc. - CFO, Corporate Secretary, & Treasurer
* Lynn Kirkpatrick
Ensysce Biosciences, Inc. - CEO & President

=====================
Questions and Answers
--------------------------------------------------------------------------------
Bob Gower, Ensysce Biosciences, Inc. - Chairman of the Board [1]
--------------------------------------------------------------------------------
We'll now open the floor to questions from stockholders.

Lynn will field your questions to the company's leadership team and independent auditor. And as a reminder, you are able to ask questions using the ask-a-question box on the left side of your screen. Please note that the rules of conduct apply to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot